Iceland· IS-EU/1/18/1308/001-003

Vyxeos liposomal

A cytarabine and daunorubicin product containing daunorubicinum inn,cytarabinum inn, registered in Iceland by Jazz Pharmaceuticals Ireland Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC L01XY01

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedVyxeos liposomalATCL01XY01REGISTER NO.IS-EU/1/18/1308/001-0…PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Cytarabine and daunorubicin is registered in 13 of 19 countries.

Countries holding a registration under ATC L01XY01 (cytarabine and daunorubicin), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 8 of them publish a price we can compare per daily dose

Cytarabine and daunorubicin · ATC L01XY01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Daunorubicinum INN,Cytarabinum INN
Manufacturer
Jazz Pharmaceuticals Ireland Ltd
Country
Iceland (IS)
ATC code
L01XY01
ATC class
Cytarabine and daunorubicin
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e217ed8b-ec8b-4413-977e-50ab3e906587
GET /v1/drugs/e217ed8b-ec8b-4413-977e-50ab3e906587?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stofn fyrir innrennslisþykkni, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "L01XY01",
  "marketed": false,
  "strength": "44 mg/ 100 mg",
  "ma_number": "EU/1/18/1308/001-003",
  "substance": "Daunorubicinum INN,Cytarabinum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "43335"
}

See everything about cytarabine and daunorubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.